Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by jopatcloon Mar 29, 2024 7:34am
68 Views
Post# 35959876

RE:RE:New Press Release - Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call

RE:RE:New Press Release - Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
Pandor..pandor...the Soft bashing as always are denigrating on Ventripoint for good news! you call me again in your message!Added Mr. MacNaught “Over the next month we will continue
to focus on closing sales for VMS+3.2,

boyfriend to our biggest fan of the vulture at Granhamwalk manipulator who has an agenda to get your shares...just go see their games...they talk to each other and see the game on ats...show them on the TSX- V has low volume their manipulation of low prices to scare new people...beware of this wolf pack...
Pandor the Soft bashing who are you on this the sheep at GranhamWalk!on ceo ! here same gang who like to talk among themselves for like...
Sales news at any time! 4.0 exciting moment,
Dr.George Adams,Bart Hendriks,Hugt MacNaught,Dr.luc Mertens and team... "This is the best Board I have ever worked with and you should be assured by its commitment and expertise." - George Adams ,
Go Dr.Adams the visionary with the good news to scare away the Soft bashing team !

high rate of success.to focus on closing sales .Multiple!$$

Added Mr. MacNaught “Over the next month we will continue
to focus on closing sales for VMS+3.2,
 preparing for the AEPC conference in May, submitting VMS+4.0 to FDA for 510(k) clearance and optimizing our internal processes to support growth. During this time, I will be devoting more time and attention to the U.S. market to ensure that Ventripoint achieves a high rate of success.
Date Ex Sym Open High Low Close Chg Total Vol #Tr Bid Ask V-TSX-V U-NEO ATS A-Alpha O-Omega P-Pure X-Chi-X H-CX2 D-CXD L-LiquidNet M-TriAct I-Instinet Y-Lynx S-CS2
2024-03-28 V VPT 0.225 0.24 0.22 0.225   217,770 69 0.22 0.225 42,900 11,500 112,500 18,000 300   30,000     2,102    
game vultures on TSX-V
<< Previous
Bullboard Posts
Next >>